On July 3, MetLife rose 3.12% in regular trading, trading at $89.915/share, with turnover of $204 million. The stock continued its upward momentum following the company's disclosure of Q2 variable investment income guidance.

On the news front, MetLife filed with the SEC on June 29, disclosing that Q2 pre-tax variable investment income is expected to range between $220 million and $270 million, while maintaining its full-year guidance at $1.6 billion. Combined with Q1 actual variable investment income of $518 million — which surged 58% year-over-year driven by improved private equity returns — first-half income totals approximately $738 million to $788 million, representing 46% to 49% of the annual target, indicating solid execution progress.

MetLife's Q1 adjusted EPS of $2.42 beat the consensus estimate of $2.27 by 6.6%. The company will report full Q2 results on August 5, with analysts expecting adjusted EPS of $2.41. Analysts remain broadly constructive, with a consensus overweight rating and a mean price target of $93.73, with KBW maintaining an outperform rating with a $98 target.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)